Clinical Trial Update: Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin [Phase 4]

View source ↗

Summary

Phase 4 cluster randomized trial evaluating co-administration of azithromycin, albendazole, and ivermectin for trachoma and lymphatic filariases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Filariasis
• Trachoma

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Azithromycin (azithromycin)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Trachoma, Lymphatic Filariases | Phase 4 | Status: COMPLETED